Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Nov-22 9:20 PM View:  | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 09-Nov-22 | Private Sale | 387 | $292.90 | $113,352.00 | (6%) 7.02K to 6.63K | |
| 10-Nov-22 9:18 PM View: | Kullman Ellen Jamison Director | Amgen Inc. (AMGN) | 08-Nov-22 | Grant | 222 | -- | -- | 2% 9.89K to 10.11K | |
| 08-Nov-22 6:38 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 08-Nov-22 | Sale | 545 | $293.54 | $159,977.00 | (4%) 13.65K to 13.1K | |
| 10-Nov-22 9:16 PM View: | Ishrak Omar Director | Amgen Inc. (AMGN) | 08-Nov-22 | Grant | 222 | -- | -- | 11% 2.08K to 2.3K | |
| 10-Nov-22 9:14 PM View: | Drake Michael V Director | Amgen Inc. (AMGN) | 08-Nov-22 | Grant | 171 | -- | -- | 27% 0.64K to 0.81K | |
| 08-Nov-22 6:38 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 05-Nov-22 | Payment of Exercise | 240 | $269.04 | $64,569.60 | (2%) 13.89K to 13.65K | |
| 08-Nov-22 6:44 PM View: | Miller Derek SVP, Human Resources | Amgen Inc. (AMGN) | 05-Nov-22 | Payment of Exercise | 63 | $269.04 | $16,949.50 | (1%) 6.04K to 5.97K | |
| 08-Nov-22 6:42 PM View: | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 05-Nov-22 | Payment of Exercise | 168 | $269.04 | $45,198.70 | (2%) 7.18K to 7.02K | |
| 08-Nov-22 6:43 PM View: | Louie Linda H. VP, Finance & CAO | Amgen Inc. (AMGN) | 05-Nov-22 | Payment of Exercise | 45 | $269.04 | $12,106.80 | (< 1%) 9.32K to 9.28K | |
| 03-Nov-22 9:36 PM View: | Louie Linda H. VP, Finance & CAO | Amgen Inc. (AMGN) | 02-Nov-22 | Payment of Exercise | 125 | $272.06 | $34,007.50 | (1%) 9.45K to 9.32K | |
| 03-Nov-22 9:38 PM View: | Reese David M EVP, Research and Development | Amgen Inc. (AMGN) | 02-Nov-22 | Payment of Exercise | 2,440 | $272.06 | $663,826.00 | (5%) 50.58K to 48.14K | |
| 01-Nov-22 7:47 PM View: | Griffith Peter H. EVP & CFO | Amgen Inc. (AMGN) | 01-Nov-22 | Payment of Exercise | 3,030 | $270.35 | $819,160.00 | (11%) 27.7K to 24.68K | |
| 01-Nov-22 7:46 PM View: | Graham Jonathan P EVP, Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 01-Nov-22 | Payment of Exercise | 1,644 | $270.35 | $444,455.00 | (5%) 35.61K to 33.96K | |
| 23-Aug-22 5:37 PM View: | Gordon Murdo EVP Global Commercial Ops | Amgen Inc. (AMGN) | 22-Aug-22 | Gift | 400 | -- | -- | (< 1%) 47.88K to 47.48K | |
| 22-Aug-22 9:03 PM View: | Williams R Sanders Director | Amgen Inc. (AMGN) | 22-Aug-22 | Private Sale (Planned) | 200 | $249.96 | $49,992.00 | (4%) 5.5K to 5.3K | |
| 19-Aug-22 6:16 PM View: | Eckert Robert Director | Amgen Inc. (AMGN) | 18-Aug-22 | Private Sale | 6,600 | $249.00 | $1,643,380.00 | (24%) 27.78K to 21.18K | |
| 12-Aug-22 5:38 PM View: | Eckert Robert Director | Amgen Inc. (AMGN) | 10-Aug-22 | Payment of Exercise | 6,791 | $252.09 | $1,711,940.00 | (20%) 34.58K to 27.78K | |
| 12-Aug-22 5:38 PM View: | Eckert Robert Director | Amgen Inc. (AMGN) | 10-Aug-22 | Option Exercise | 20,000 | $85.59 | $1,711,800.00 | 137% 14.57K to 34.58K | |
| 11-Aug-22 5:39 PM View: | Ishrak Omar Director | Amgen Inc. (AMGN) | 09-Aug-22 | Grant | 131 | -- | -- | 7% 1.94K to 2.07K | |
| 11-Aug-22 5:38 PM View: | Drake Michael V Director | Amgen Inc. (AMGN) | 09-Aug-22 | Grant | 634 | -- | -- | 100% 0 to 0.63K | |
| 11-Aug-22 5:40 PM View: | Kullman Ellen Jamison Director | Amgen Inc. (AMGN) | 09-Aug-22 | Grant | 131 | -- | -- | 1% 9.68K to 9.81K | |
| 02-Aug-22 9:24 PM View: | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 31-Jul-22 | Payment of Exercise | 217 | $247.47 | $53,701.00 | (3%) 7.38K to 7.16K | |
| 02-Aug-22 9:22 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 31-Jul-22 | Payment of Exercise | 1,229 | $247.47 | $304,141.00 | (8%) 15.05K to 13.82K | |
| 23-May-22 9:19 PM View: | Williams R Sanders Director | Amgen Inc. (AMGN) | 23-May-22 | Private Sale (Planned) | 600 | $250.00 | $150,000.00 | (10%) 6.1K to 5.5K | |
| 19-May-22 9:54 PM View: | Holley Charles M Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 12% 7.06K to 7.91K | |
| 19-May-22 9:51 PM View: | Austin Wanda M Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 21% 4.03K to 4.89K | |
| 19-May-22 9:52 PM View: | Eckert Robert Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 6% 13.61K to 14.46K | |
| 19-May-22 9:55 PM View: | Jacks Tyler Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 7% 12.72K to 13.58K | |
| 19-May-22 9:56 PM View: | Miles Amy E Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 68% 1.26K to 2.12K | |
| 19-May-22 9:57 PM View: | Sugar Ronald D Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 5% 17.3K to 18.16K | |
| 19-May-22 9:56 PM View: | Kullman Ellen Jamison Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 10% 8.75K to 9.61K | |
| 19-May-22 9:53 PM View: | Garland Greg C. Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 9% 9.86K to 10.72K | |
| 19-May-22 9:58 PM View: | Williams R Sanders Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 16% 5.25K to 6.1K | |
| 19-May-22 9:52 PM View: | Druker Brian Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 23% 3.75K to 4.6K | |
| 19-May-22 9:54 PM View: | Ishrak Omar Director | Amgen Inc. (AMGN) | 17-May-22 | Grant | 855 | -- | -- | 79% 1.08K to 1.93K | |
| 12-May-22 8:11 PM View: | Graham Jonathan P EVP, Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 12-May-22 | Gift | 2,000 | -- | -- | (5%) 37.33K to 35.33K | |
| 10-May-22 7:45 PM View: | Graham Jonathan P EVP, Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 10-May-22 | Market Sale | 13,500 | $241.81 | $3,264,450.00 | (27%) 50.83K to 37.33K | 5% |
| 09-May-22 7:08 PM View: | Khosla Rachna SVP, Business Development | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 37 | $236.10 | $8,735.70 | (< 1%) 7.38K to 7.34K | 2% |
| 09-May-22 7:05 PM View: | Griffith Peter H. EVP & CFO | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 589 | $236.10 | $139,063.00 | (2%) 27.93K to 27.34K | 2% |
| 09-May-22 7:09 PM View: | Louie Linda H. VP, Finance & CAO | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 15 | $236.10 | $3,541.50 | (< 1%) 9.42K to 9.4K | 2% |
| 09-May-22 7:07 PM View: | Grygiel Nancy A. SVP & CCO | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 52 | $236.10 | $12,277.20 | (< 1%) 15.01K to 14.96K | 2% |
| 09-May-22 7:00 PM View: | Bradway Robert A Chairman, CEO and President Director | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 2,017 | $236.10 | $476,214.00 | (< 1%) 621.86K to 619.84K | 2% |
| 09-May-22 7:12 PM View: | Reese David M EVP, Research and Development | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 575 | $236.10 | $135,758.00 | (1%) 50.88K to 50.31K | 2% |
| 09-May-22 7:10 PM View: | Miller Derek SVP, Human Resources | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 49 | $236.10 | $11,568.90 | (< 1%) 6.05K to 6.01K | 2% |
| 09-May-22 7:14 PM View: | Santos Esteban EVP, Operations | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 589 | $236.10 | $139,063.00 | (< 1%) 59.05K to 58.46K | 2% |
| 09-May-22 7:03 PM View: | Graham Jonathan P EVP, Gen. Counsel & Secy. | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 574 | $236.10 | $135,521.00 | (1%) 51.41K to 50.83K | 2% |
| 09-May-22 7:02 PM View: | Gordon Murdo EVP Global Commercial Ops | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 603 | $236.10 | $142,368.00 | (1%) 48.39K to 47.78K | 2% |
| 04-May-22 7:44 PM View: | Bradway Robert A Chairman, CEO and President Director | Amgen Inc. (AMGN) | 03-May-22 | Payment of Exercise | 2,692 | $230.92 | $621,637.00 | (< 1%) 624.55K to 621.86K | |
| 04-May-22 8:07 PM View: | Reese David M EVP, Research and Development | Amgen Inc. (AMGN) | 03-May-22 | Payment of Exercise | 770 | $230.92 | $177,808.00 | (1%) 51.65K to 50.88K | |
| 04-May-22 8:05 PM View: | Miller Derek SVP, Human Resources | Amgen Inc. (AMGN) | 03-May-22 | Payment of Exercise | 54 | $230.92 | $12,469.70 | (< 1%) 6.11K to 6.05K |
